NCT01293435

Study Evaluating Management of Patients With Community-Acquired Pneumonia (CAP) or Complicated Skin Infections

Observational Study to Assess Clinical Management Patterns in Patients With Hospitalised Community-Acquired Pneumonia (CAP) or Complicated Skin and Skin Structure Infections (cSSSI)

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 4,035 (actual)
• Sponsor: AstraZeneca · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

This study will collect real-life data from patients with community acquired pneumonia (CAP) OR complicated skin and skin structure infections (cSSSI) to assess the burden of the disease, review the treatment pathways, evaluate how health resources are used and identify any areas of unmet medical needs. The aim of the study is to compare how patients who are admitted to hospital with CAP or cSSSI are managed across Europe. This will be done by collecting data to understand the patient and disease characteristics, current practice of treatment, and outcomes for the patient. Overall 4000 patients will be recruited from 10 European countries.

Conditions

• Community Acquired Pneumonia (CAP)
• Complicated Skin and Skin Structures Infections (cSSSI)

Timeline

• Start date: 2011-03-01
• Primary completion: 2011-06-01
• Completion: 2011-06-01
• First posted: 2011-02-10
• Last updated: 2012-09-07

Locations

163 sites across 10 countries: Belgium, France, Germany, Greece, Italy, Netherlands, Portugal, Spain, Turkey (Türkiye), United Kingdom